SA

Saraswathi Aenugula

Active Director Director DIN 08898481
DIN 08898481 First appointment Sep 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Saraswathi Aenugula

Data last updated:

Saraswathi Aenugula is a Director at Oxiant Pharmaceuticals Private Limited (since 2020). The company operates in Pharma.

DIN 08898481
Primary Designation Director
Industry Pharma
First Appointment 30 Sep 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Sep 20202020Active

Board colleagues of Saraswathi Aenugula

Directorship timeline

Open interactive timeline →
Oxiant Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Saraswathi Aenugula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saraswathi Aenugula

Saraswathi Aenugula currently holds 1 directorship: Oxiant Pharmaceuticals Private Limited (Director, since 30 Sep 2020).

Saraswathi Aenugula was first appointed on 30 Sep 2020 as Director at Oxiant Pharmaceuticals Private Limited.

The current boards of Saraswathi Aenugula's companies include Padmaja Vepakomma (Oxiant Pharmaceuticals Private Limited), Subramanya Boddanapalli Venkata Prasad (Oxiant Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available